Innovid Corp (CTV) Stock Analysis

Verdict: AVOID

High gross margins are trapped by persistent operating losses and a sharp bearish shift in analyst sentiment.

Investment score: 38/100

Analysis as of

Is Innovid Corp stock worth reviewing? The TradeMates thesis

The TradeMates model views CTV as a high-risk asset with deteriorating sentiment. Despite an impressive 76.7% gross margin and a healthy current ratio of 3.51, the company remains GAAP unprofitable with erratic earnings quality. Recent analyst downgrades and a price-to-sales premium over peers (3.39x vs 2.26x for PUBM) make the risk-reward profile unfavorable for the next 90 days.

7-factor investment score

Innovid Corp opportunities and risks

What speaks for CTV

What speaks against CTV

Peers and competitors

Trailing-twelve-month ratios
TickerP/EP/SEV/EBITDAGross marginNet marginFCF yield
CTVn/a3.4xn/a75.8%-22.8%0.4%
IBTAn/a2.5x94.3x78.0%-2.1%9.0%
MNTN30.9x2.4x14.6x79.7%7.8%7.2%
PUBMn/a2.3x23.9x63.2%-6.2%6.7%
ADVn/a0.1x24.7x9.8%-6.8%11.8%
BOCn/a3.8x58.8x76.0%-12.1%-1.9%
Peer mediann/a2.4x24.7x76.0%-6.2%7.2%

Frequently asked questions about Innovid Corp (CTV)

Is CTV stock a good investment?

The TradeMates model rates Innovid Corp as AVOID with an investment score of 38/100. The TradeMates model views CTV as a high-risk asset with deteriorating sentiment. Despite an impressive 76.7% gross margin and a healthy current ratio of 3.51, the company remains GAAP unprofitable with erratic earnings quality. Recent analyst downgrades and a price-to-sales premium over peers (3.39x vs 2.26x for PUBM) make the risk-reward profile unfavorable for the next 90 days. This is algorithmic model output, not personal investment advice.

Is CTV stock a buy?

The TradeMates model verdict for CTV is AVOID with an investment score of 38/100. Treat this as a model signal to review, not a personal buy recommendation.